38112003: un (valeur de l'attribut)

SNOMED CT Concept\valeur de l'attribut\nombre\un

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	est un(e) (attribut)	modificateur adjectival général	false	Inferred relationship	Some
un	est un(e) (attribut)	nombre	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely ixazomib (as ixazomib citrate) 4 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely panobinostat (as panobinostat lactate) 20 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely panobinostat (as panobinostat lactate) 20 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Ixazomib (as ixazomib citrate) 3 mg oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Ixazomib (as ixazomib citrate) 3 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ixazomib (as ixazomib citrate) 2.3 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ixazomib (as ixazomib citrate) 2.3 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Lomitapide (as lomitapide mesylate) 5 mg oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Lomitapide (as lomitapide mesylate) 5 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely lomitapide (as lomitapide mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely lomitapide (as lomitapide mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely lomitapide (as lomitapide mesilate) 20 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely lomitapide (as lomitapide mesilate) 20 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing only lomitapide (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only lomitapide in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Silver sulfadiazine 10 mg/g cutaneous cream	Count of base of active ingredient	False	un	Inferred relationship	Some
Silver sulfadiazine 10 mg/g cutaneous cream	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely isavuconazole (as isavuconazonium sulfate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely isavuconazole (as isavuconazonium sulfate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cabozantinib (as cabozantinib s-malate) 20 mg oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Cabozantinib (as cabozantinib s-malate) 20 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Silver sulfadiazine only product in cutaneous dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Silver sulfadiazine only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cabozantinib (as cabozantinib s-malate) 80 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cabozantinib (as cabozantinib s-malate) 80 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Nintedanib (as nintedanib esilate) 100 mg oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Nintedanib (as nintedanib esilate) 100 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Isavuconazonium only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Rabies human immune globulin only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only eliglustat in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only afamelanotide in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only Neisseria meningitidis capsular polysaccharide antigen (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely glucosamine (as glucosamine sulfate potassium chloride) 400 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely glucosamine (as glucosamine sulfate potassium chloride) 400 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cholecalciferol 25 microgram oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Cholecalciferol 25 microgram oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely colecalciferol 175 microgram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely colecalciferol 175 microgram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cholecalciferol 625 microgram oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Cholecalciferol 625 microgram oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cholecalciferol 625 microgram/mL oral solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Cholecalciferol 625 microgram/mL oral solution	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Remdesivir only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Remdesivir only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Remdesivir 100 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Remdesivir 100 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Bempedoic acid only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only bempedoic acid in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Bempedoic acid 180 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Bempedoic acid 180 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Selumetinib only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Selumetinib only product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely selumetinib 25 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely selumetinib 25 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely selumetinib 10 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely selumetinib 10 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing only human tetanus immunoglobulin in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Equine diphtheria antitoxin only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Equine diphtheria antitoxin only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Pemigatinib 4.5 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Pemigatinib 4.5 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Pemigatinib 9 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Pemigatinib 9 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Pemigatinib 13.5 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Pemigatinib 13.5 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing only pemigatinib in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only pemigatinib (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Tucatinib 50 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Tucatinib 50 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely tucatinib 150 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely tucatinib 150 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Tucatinib only product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only tucatinib (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Francisella tularensis antigen only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
YF yellow fever unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
PLAG plague unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
TBE tick-borne encephalitis unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only Dengue virus antigen (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only Ebolavirus antigen (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Adenovirus antigen only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Coxiella burnetii antigen only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
JE Japanese encephalitis unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only inactivated whole Japanese encephalitis virus antigen (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Rab rabies unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Sma smallpox unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Corynebacterium diphtheriae antigen only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Low dose Corynebacterium diphtheriae antigen only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
R rubella unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Mumps orthorubulavirus antigen only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Mu mumps live unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Poliomyelitis unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
IPV poliomyelitis inactivated unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
T tetanus unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Cytomegalovirus antibody only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Hepatitis A virus antigen only paediatric vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Hepatitis A virus antigen only adult vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
HA hepatitis A unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide Vi antigen (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Bordetella pertussis antigen only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some

Start Previous Page 108 of 217 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
615211000077111	un (valeur de l'attribut)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
771016011	One (qualifier value)	en	Fully specified name	Inactive	Only initial character case insensitive (core metadata concept)	SNOMED CT core